Forgot your password?

Forgot your username?


Progress on Antibe’s Non-Steroidal Anti-Inflammatory Drug

Posted on 15 Jun 2015
Results of additional testing have been recently announced by Antibe Therapeutics pertaining to the progress of the developmental procedures being conducted by the company for their ATB-346 drug. These recent validation data show further proof that ATB-346 can be effective even if adm

Wafergen’s Smartchip Mydesign Genomic Technology to be Employed by Procter & Gamble

Posted on 11 May 2015
Wafergen Biosystems and Procter & Gamble recently announced their industrial partnership that involves the latter utilizing the former’s specialized quantitative PCR System namely SmartChip MyDesign. Proctor & Gamble will make use of Wafergen’s product for researches involving

Cellular Biomedicine Group Joins Force With Huntsworth Health For KOL Advocacy On Clinical Research For Knee Osteoarthritis

Posted on 11 May 2015
Cellular Biomedicine Group, Inc. (CBMG) has took on Hunstworth Health to put in order a team of medical experts for a global KOL advocacy campaign for CBMG’s Rejoin clinical trials. The clinical trials are for Rejoin which is a human adipose-derived mesenchymal progenitor cell (haMPC)

Capnia Develop Cluster Headache Medicine with Partner Clinvest

Posted on 11 May 2015
A recently announced Memorandum of Understanding (MOU) between Capnia, Inc. and Clinvest, a Banyan Group, Inc. division, has brought about the formation of the collaboration between the two parties to develop a cure for cluster headache with the use of the former’s proprietary nasal C

Aeolus Pharma’s AEOL 10150 Declared Orphan Drug for IPF and Lung-ARS

Posted on 11 May 2015
The US FDA recently announced that the experimental drug being developed by Aeolus Pharmaceuticals, Inc. AEOL 10150 has been granted the Orphan Drug status. This status is being given to medicines that are dedicated to treating rare medical conditions that affects a very small percent

Cavendish Global Health Impact Forum

Posted on 24 Nov 2014
Cavendish Global 500px-Blenheim_Palace_cropped

CHI 2014 Annual Meeting on Thursday, November 20, 2014

Posted on 24 Nov 2014
This Thursday, at the California Healthcare Institute’s 2014 Annual Meeting, thought leaders will come together to address one of the most significant healthcare changes in years, the Affordable Care Act. Prominent speakers, such as Paul G. Yock, M.D. and many more, will analyze the u

Enable’s Innovative Wearable Injector

Posted on 24 Nov 2014
Enable expects that there will be over 250 biologic </div></div><div class=

Health & Biotech Summit in New York Notes CEOs Wanted

Posted on 24 Nov 2014
According to Gotsch, CEO of Partnership for New York, “New York uniquely produces more innovative medical technology than any other region, but it lags in new company formation.”